Medicenna Therapeutics Corp. (MDNA.TO) TSX
0.63
+0.01(+1.61%)
Currency In CAD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.63
+0.01(+1.61%)
Currency In CAD
| Market Cap | 75.14M |
| Enterprise Value | 50.47M |
| P/E Ratio | -4.05 |
| PEG Ratio | -0.09 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 8.46 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.52 |
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.99 |
| Return On Equity | -1.04 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -55,000 |
| EBITDA | -12.98M |
| Net Income | -11.81M |
| Diluted EPS | -0.15 |
| Total Cash | 10.61M |
| Total Cash/Share | 0.13 |
| Total Debt | 205,000 |
| Total Debt/Equity | 0.03 |
| Current Ratio | 2.68 |
| Book Value Per Share | 0.07 |
| 52-Week Change | -42.73 |
| 52-Week High | 1.97 |
| 52-Week Low | 0.54 |
| Moving Average 50 Days | 0.67 |
| Moving Average 200 Days | 0.98 |
| Average Volume | 101,516 |
| Shares Outstanding | 68.73M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |